Document Detail


Evaluation of Different Strategies for Post-Exposure Treatment of Ebola Virus Infection in Rodents.
MedLine Citation:
PMID:  23205319     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Zaire Ebola virus (ZEBOV) is a pathogen that causes severe hemorrhagic fever in humans and non-human primates. There are currently no licensed vaccines or approved treatments available against ZEBOV infections. The goal of this work was to evaluate different treatment strategies in conjunction with a replication deficient, recombinant human adenovirus serotype 5-based vaccine expressing the Zaire Ebola virus glycoprotein (Ad-CAGoptZGP) in Ebola infected mice and guinea pigs.Guinea pigs were treated with Ad-CAGoptZGP in combination with different treatment strategies after challenge with guinea pig adapted-ZEBOV (GA-ZEBOV). B10.BR mice were used to further characterize efficacy and immune responses following co-administration of Ad-CAGoptZGP with the most effective treatment: AdHu5 expressing recombinant IFN-α (hereafter termed DEF201) after challenge with a lethal dose of mouse adapted-ZEBOV (MA-ZEBOV).In mice, DEF201 treatment was able to elicit full protection against a lethal dose of MA-ZEBOV when administered 30 minutes after infection. In guinea pigs the Ad-CAGoptZGP and DEF201 combination therapy elicited full protection when treated 30 minutes post-exposure and were a superior treatment to Ad-CAGoptZGP supplemented with recombinant IFN-α protein. Further analysis of the immune response revealed that addition of DEF201 to Ad-CAGoptZGP enhances the resulting adaptive immune response against ZGP. The results highlight the importance of the innate immune response in the prevention of ZEBOV pathogenesis and support further development of the Ad-CAGoptZGP with DEF201 treatment combination for post-exposure therapy against ZEBOV infection.
Authors:
Jason S Richardson; Gary Wong; Stéphane Pillet; Samantha Schindle; Jane Ennis; Jeffrey Turner; James E Strong; Gary P Kobinger
Related Documents :
25277889 - Cd160 expression defines a uniquely exhausted subset of t lymphocytes in htlv-1 infection.
25258539 - Bloodstream infections in patients with hematological malignancies: which is more fatal...
25473049 - Regulatory t cells resist virus infection-induced apoptosis.
19542009 - The interaction between listeria monocytogenes and the host gastrointestinal tract.
25182329 - Genes contributing to staphylococcus aureus fitness in abscess- and infection-related e...
25240819 - New approaches to the treatment of biofilm-related infections.
3388729 - Relative contributions of late dry-season and early rains pasture contaminations with t...
22694849 - In vitro and in vivo silencing of plasmodial dhs and eif-5a genes in a putative, non-ca...
25279829 - The effect of c. burnetii infection on the cytokine response of pbmcs from pregnant goats.
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Journal of bioterrorism & biodefense     Volume:  -     ISSN:  2157-2526     ISO Abbreviation:  J Bioterror Biodef     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2012-12-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101575135     Medline TA:  J Bioterror Biodef     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The real face of juvenile polyposis syndrome.
Next Document:  Poly[(ethylene oxide)-co-(methylene ethylene oxide)]: A hydrolytically-degradable poly(ethylene oxid...